By uncovering complex interactions between different omics layers and identifying connections between key molecular players such as PDIA6 and DDAH1, multiomics analysis holds great promise for advancing precision medicine and improving outcomes in pancreatic cancer patients. This evidence concerns the gene PDIA6 and familial pancreatic carcinoma.